Red Wine Component Revs Endurance in Mice
Posted on: Friday, 17 November 2006, 09:00 CST
A red wine component shown to extend the lives of mice and protect them from obesity also has been shown to boost endurance, French researchers said.
Besides confirming resveratrol's benefits, the researchers offered insights into how the substance works, The Washington Post said Friday.
Resveratrol apparently raises the metabolism so muscles burn more energy and work more efficiently, researchers said. Mice fed large doses could run twice as far as they would normally. Researchers said the same triggering mechanism is likely to be in humans as well.
This compound could have many applications -- treating obesity and diabetes, improving human endurance, helping the frail, said Johan Auwerx, a professor at the Institute of Genetics and Molecular and Cellular Biology in Strasbourg, France, who led the research published online and in the Dec. 15 issue of the journal Cell.
Auwerx said more research is needed, especially to see if the approach is safe for humans. Humans would have to take hundreds of resveratrol pills or drink hundreds of glasses of wine a day to get equivalent levels tested on the mice.
Resveratrol is found in red wine, grapes and other foods, including peanuts.
Source: United Press International
Related Articles
- Cardiologist Praises Latest Resveratrol/Red Wine Research
- Reminder - Cisco CSO, Executives to Share Global Research Revealing the Human Side of Security -- From Employee Perceptions and Behavior to Trends, Threats, and Risk Management Tips
- Cisco CSO, Executives to Share Global Research Revealing the Human Side of Security -- From Employee Perceptions and Behavior to Trends, Threats, and Risk Management Tips
- Research Indicates Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack By the Human Immune System
- Researcher Mum in Human Tissue Hearing
- HepaLife's Artificial Liver Research Passes Critical Human Plasma Milestone
- Chemicon International, Inc. Enters into a License to Commercialize Research Products Utilizing Human Embryonic Stem Cell Technology From Wisconsin Alumni Research Foundation (WARF)
- Research and Markets: Human Trials of Angiomodulatory Compounds Are At Last Beginning to Yield Commercial Products With Proven Efficacy
- Behavioral Scientists to Create First Research-Quality Simulated Human Face With Silicon Graphics Onyx4 Visualization System
- Over $4.5 Billion Spent Worldwide on Industrial and Academic Research to Understand Human Gene Function
User Comments (0)
RSS Feeds